CXCL12 and Miyoshi myopathy: We also reported that pDCs derived from the BM of MM patients have a decreased capacity to stimulate T cell response, support growth of MM, and contribute to drug resistance through secretion of cytokines such as SDF-1 (CXCL12) and IL-3[62].